# Alertix Veterinary Diagnostics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/alertix-veterinary-diagnostics

- Industry: Medical Devices & Equipment
- Headquarters: Kalmar, Sweden
- Website: www.alertixvet.com
- Total disclosed funding: $0.4M
- Latest round: Angel (Oct 11, 2019)
- Investors on record: 1

## About

Since its Founding in 2017 in Kalmar Sweden, Veterinary Diagnostics AB has been focused on commercializing discoveries from Swedish veterinary medical biotech research. In particular, the early detection of cancer in animals using an immunodiagnostic assay for measuring the presence of the enzyme thymidine kinase (TK1) in blood which is an indicator of tumor cell growth and the presence of cancer. 

The Firm currently has one product line the Alertix canine, a rapid test stick for the early detection of cancer in dogs.  The test is said to provide a more complete picture, detecting both tumors and blood cancers in dogs, as well as being simpler to use, more cost effective and gentler on the patients than current tests.  The test is currently available to veterinary clinics and laboratories located in Sweden and Scandinavia.

In 2019 the firm received SEK 4 million in capital investment from local angel investors in Sweden, matched by a SEK 2.5 million investment made by the Swedish government through Almi Invest, to launch the test for dogs. The company is now focused on developing a similar test for both cats and horses as well as introducing the tests into the US and European markets.

## Funding rounds

- Angel, Oct 11, 2019, $0.4M — ALMI Invest

## Investors

- ALMI Invest — Angel